Search

everythinglearnresearchcommunity

for

Search:↓

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

Cyperus rotundus oil effectively reduces unwanted hair without side effects.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The home-use IPL device effectively reduced hair and delayed its regrowth after six months of use, with users happy and no negative side effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Biodegradable microneedle patches help topical steroids work better for prurigo nodularis.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Erosive pustular dermatosis of the scalp is a rare condition that causes scarring hair loss, mainly in older women, and requires ongoing treatment.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Reduced neurosteroid production increases fear in mice, suggesting potential PTSD treatments.

Females have a higher lifetime risk of alopecia areata than males.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Actinic keratosis is more common in older men with certain genetic traits, but smoking seems to reduce its odds.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Lower testosterone levels may increase heart failure risk in older men.

Pu-erh tea reduces hair loss risk in offspring.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Male and female mice handle stress differently.

Male and female mice handle stress differently.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.